PB2079: INTERIM REPORT OF BENDAMUSTINE PLUS RITUXIMAB AS FIRST-LINE INDUCTION THERAPY WITH OR WITHOUT LENALIDOMIDE MAINTENANCE THERAPY IN CHINESE PATIENTS WITH INHL OR EMCL: A MULTI-CENTER PROSPECTIVE TRIAL

Authors: H. Wang, Q. He, R. Zhao, L. Xie, J. Ma, C. Liu, K. Lu, H. Wei, D. Liu, L. Xing, X. Deng, Z. Sun, X. Chu, N. Gao, Y. Zhong, Y. Sun, H. Zhang, H. Zhang, W. Xu, Z. Li

Published: 2022-06-24

DOI: 10.1097/01.hs9.0000851148.10454.66

Source: Full article

---

Abstract

No abstract found.